HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of candidate vaccine approaches for MERS-CoV.

Abstract
The emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) as a cause of severe respiratory disease highlights the need for effective approaches to CoV vaccine development. Efforts focused solely on the receptor-binding domain (RBD) of the viral Spike (S) glycoprotein may not optimize neutralizing antibody (NAb) responses. Here we show that immunogens based on full-length S DNA and S1 subunit protein elicit robust serum-neutralizing activity against several MERS-CoV strains in mice and non-human primates. Serological analysis and isolation of murine monoclonal antibodies revealed that immunization elicits NAbs to RBD and, non-RBD portions of S1 and S2 subunit. Multiple neutralization mechanisms were demonstrated by solving the atomic structure of a NAb-RBD complex, through sequencing of neutralization escape viruses and by constructing MERS-CoV S variants for serological assays. Immunization of rhesus macaques confers protection against MERS-CoV-induced radiographic pneumonia, as assessed using computerized tomography, supporting this strategy as a promising approach for MERS-CoV vaccine development.
AuthorsLingshu Wang, Wei Shi, M Gordon Joyce, Kayvon Modjarrad, Yi Zhang, Kwanyee Leung, Christopher R Lees, Tongqing Zhou, Hadi M Yassine, Masaru Kanekiyo, Zhi-yong Yang, Xuejun Chen, Michelle M Becker, Megan Freeman, Leatrice Vogel, Joshua C Johnson, Gene Olinger, John P Todd, Ulas Bagci, Jeffrey Solomon, Daniel J Mollura, Lisa Hensley, Peter Jahrling, Mark R Denison, Srinivas S Rao, Kanta Subbarao, Peter D Kwong, John R Mascola, Wing-Pui Kong, Barney S Graham
JournalNature communications (Nat Commun) Vol. 6 Pg. 7712 (Jul 28 2015) ISSN: 2041-1723 [Electronic] England
PMID26218507 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • DNA, Viral
  • Immunoglobulin G
  • Spike Glycoprotein, Coronavirus
  • Vaccines, DNA
  • Viral Vaccines
Topics
  • Animals
  • Antibodies, Monoclonal (immunology)
  • Antibodies, Neutralizing (immunology)
  • Antibodies, Viral (immunology)
  • Coronavirus Infections (prevention & control)
  • DNA, Viral (immunology)
  • Female
  • HEK293 Cells
  • Humans
  • Immunoglobulin G (immunology)
  • Macaca mulatta
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Middle East Respiratory Syndrome Coronavirus (immunology)
  • Spike Glycoprotein, Coronavirus (immunology)
  • Vaccines, DNA (immunology)
  • Viral Vaccines (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: